4
Changes in Ownership
Werewolf Therapeutics, Inc. Filed Acc 0001231919-25-000507
10% owner sold 209,652 shares at an average $0.96 ($200,665)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GADICKE ANSBERT 10% owner | 2025-11-13 | Sale 10b5-1 | −90,951 | $0.98 | $89,132 | 5,600,240 | I |
| GADICKE ANSBERT 10% owner | 2025-11-14 | Sale 10b5-1 | −61,640 | $0.93 | $57,325 | 5,538,600 | I |
| GADICKE ANSBERT 10% owner | 2025-11-17 | Sale 10b5-1 | −57,061 | $0.95 | $54,208 | 5,481,539 | I |
| Open-market sales · 209,652 sh · avg $0.96 · $200,665 | |||||||
Loading xslF345X05/form4-11182025_121121.xml…